Share-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2021

Stock Options [Member]

Share-Based Compensation (Tables) [Line Items]

Schedule of stock option activity

	Number of Options			Weighted- Average Exercise Price per Share		Weighted- Average Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2020		3,433,515		$	1.59		2.01	$	15,220,798
Exercisable – December 31, 2020		3,400,181			1.58		1.99		15,128,796
Granted		—			—
Exercised		(3,333	)		0.15
Cancelled or Expired		(33,334	)		8.70
Outstanding – March 31, 2021		3,396,848			1.52		1.78		3,984,796
Exercisable – March 31, 2021		3,380,181			1.52		1.77		3,984,796

	Number of Options			Weighted- Average Exercise Price per Share		Weighted- Average Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2019		2,898,347		$	1.90		1.92	$	2,264,770
Exercisable – December 31, 2019		2,898,347		$	1.90		1.92	$	2,264,770
Granted		—			—
Exercised		—			—
Cancelled or Expired		(333,335	)		1.89
Outstanding – March 31, 2020		2,565,012			1.90		1.91		4,898,470
Exercisable – March 31, 2020		2,565,012			1.90		1.91		4,898,470

Warrant [Member]

Share-Based Compensation (Tables) [Line Items]

Schedule of stock option activity

	Number of Warrants			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2020		890,416		$	1.46		4.02	$	4,083,362
Exercisable – December 31, 2020		890,416		$	1.46		4.02	$	4,083,362
Granted/Issued		7,669,092			4.53
Exercised		—			—
Forfeited or Expired		(3,704	)		2.97
Outstanding – March 31, 2021		8,555,804		$	4.21		4.72	$	1,291,622
Exercisable – March 31, 2021		8,555,804		$	4.21		4.72	$	2,291,622

	Number of Warrants		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2019		167,846	$	2.85		1.96	$	258,332
Exercisable – December 31, 2019		167,846	$	2.85		1.96	$	258,332
Granted		—		—
Exercised		—		—
Forfeited or Expired		—		—
Outstanding – March 31, 2020		167,846	$	2.85		1.72	$	414,078
Exercisable – March 31, 2020		167,846	$	2.85		1.72	$	414,078

Schedule of assumptions used to estimate fair value stock options granted

	2021
Expected dividend yield	0	%
Expected volatility	39.94-45.84	%
Risk-free interest rate	0.42-0.50	%
Contractual life of warrants	5.0 years